a b s t r a c tAs a result of the foreseen increase in the luminosity of the Large Hadron Collider, the discrimination between the collision products and possible magnet quench-provoking beam losses of the primary proton beams is becoming more critical for safe accelerator operation. We report the results of ongoing research efforts targeting the upgrading of the monitoring system by exploiting Beam Loss Monitor detectors based on semiconductors located as close as possible to the superconducting coils of the triplet magnets. In practice, this means that the detectors will have to be immersed in superfluid helium inside the cold mass and operate at 1.9 K. Additionally, the monitoring system is expected to survive 20 years of LHC operation, resulting in an estimated radiation fluence of 1 Â 10 16 proton/cm 2 , which corresponds to a dose of about 2 MGy. In this study, we monitored the signal degradation during the in situ irradiation when silicon and single-crystal diamond detectors were situated in the liquid/superfluid helium and the dependences of the collected charge on fluence and bias voltage were obtained. It is shown that diamond and silicon detectors can operate at 1.9 K after 1 Â 10 16 p/cm 2 irradiation required for application as BLMs, while the rate of the signal degradation was larger in silicon detectors than in the diamond ones. For Si detectors this rate was controlled mainly by the operational mode, being larger at forward bias voltage.

No abstract

No abstract

No abstract

A: MedAustron is a synchrotron-based hadron therapy center located in Lower Austria. Accelerated proton beams with energies of 62-252 MeV/u are used to treat patients since 2016. The carbon ion beam is currently under commissioning and will provide treatment in 2019 with energies of 120-400MeV/u. Two of the four irradiation rooms are used for clinical treatment while the preparation of the Gantry beam line is ongoing. Proton beams of up to 800 MeV will be provided for non-clinical research. The Injector features three identical ECRIS from Pantechnik, two of which are used to generate the proton and the carbon beam respectively. The medical environment of the accelerator puts strict requirements on the ion source long-term stability operation. The extracted beam current from the source allow for maximum current fluctuations on the order of ±2.5% on continuous run. In this work we discuss the impact of the ion source performances on the characteristics and stability of the entire accelerator. Further, we discuss the latest progress on carbon commissioning and the future perspectives with particular emphasis on the source requirements. K: Ion sources (positive ions, negative ions, electron cyclotron resonance (ECR), electron beam (EBIS)